The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Abstract
Purpose: Although 61% of new cases of cancer occur among the elderly, recent studies indicate that the elderly comprise only 25% of participants in cancer clinical trials. Further investigation into the reasons for low elderly participation is warranted. Our objective was to evaluate the participation of the elderly in clinical trials sponsored by the National Cancer Institute (NCI) and assess the impact of protocol exclusion criteria on elderly participation. Patients and Methods: We conducted a retrospective analysis using NCI data, analyzing patient and trial characteristics for 59,300 patients enrolled onto 495 NCI-sponsored, cooperative group trials, active from 1997 through 2000. Our main outcome measure was the proportion of elderly patients enrolled onto cancer clinical trials compared with the proportion of incident cancer patients who are elderly. Results: Overall, 32% of participants in phase II and III clinical trials were elderly, compared with 61% of patients with incident cancers in the United States who are elderly. The degree of underrepresentation was more pronounced in trials for early-stage cancers than in trials for late-stage cancers (P < .001). Furthermore, protocol exclusion criteria on the basis of organ-system abnormalities and functional status limitations were associated with lower elderly participation. We estimate that if protocol exclusions were relaxed, elderly participation in cancer trials would be 60%. Conclusion: The elderly are underrepresented in cancer clinical trials relative to their disease burden. Older patients are more likely to have medical histories that make them ineligible for clinical trials because of protocol exclusions. Insurance coverage for clinical trials is one step toward improvement of elderly access to clinical trials. Without a change in study design or requirements, this step may not be sufficient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L., Fisher, E., Deutsch, M., Caplan, R., Pilch, Y., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201302 · Cited by 1,587
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Leith, C. P., Kopecky, K. J., Godwin, J., McConnell, T., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859
Treatment of Early-Stage Breast Cancer
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460030097037 · Cited by 782
Sateren, W. B., Trimble, E. L., Abrams, J., Brawley, O., Breen, N., Ford, L., McCabe, M., Kaplan, R., Smith, M., Ungerleider, R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.056 · Cited by 535
Self-citationYancik, R., & Ries, L. A. G. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70275-6 · Cited by 419
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Self-citationTejeda, H. A., Green, S. B., Trimble, E. L., Ford, L., High, J. L., Ungerleider, R. S., Friedman, M. A., & Brawley, O. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.12.812 · Cited by 269
Self-citationOncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
Benson, A. B., Pregler, J. P., Bean, J. A., Rademaker, A. W., Eshler, B., & Anderson, K. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.11.2067 · Cited by 241
Perez, E. A., Hesketh, P. J., Sandbach, J. F., Reeves, J., Chawla, S., Markman, M. M., Hainsworth, J. D., Bushnell, W., & Friedman, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.754 · Cited by 136
Hunter, C. P., Rw, F., Ar, F., Bavier, A. R., Wh, D., Ford, L., Henson, D. E., Macfarlane, D. K., Cr, S., & Yancik, R. (1987) · PubMed · Cited by 129
Factors Influencing Enrollment in Clinical Trials for Cancer Treatment
Klabunde, C. N., Bethesda, Springer, B. C., BUTLER, B., Winston-Salem, WHITE, M. S., Raleigh, & Atkins, J. (1999) · Southern Medical Journal · doi:10.1097/00007611-199912000-00011 · Cited by 99
Cancer Chemotherapy in Older Adults: A Tolerability Perspective
Kimmick, G. G., Fleming, R. A., Muss, H. B., & Balducci, L. (1997) · Drugs & Aging · doi:10.2165/00002512-199710010-00004 · Cited by 60
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
Johnson, P. R. E., & Yin, J. A. L. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04622.x · Cited by 57
Older Age — Not a Barrier to Cancer Treatment
Muss, H. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200110113451512 · Cited by 48
Underrepresentation of women in clinical drug trials
Schmucker, D. L., & Vesell, E. S. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.102 · Cited by 44
CLINICAL RESEARCH IN THE OLDER CANCER PATIENT
Muss, H. B., Cohen, H. J., & Lichtman, S. M. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70289-6 · Cited by 26
Commentary: Women, Research, and the National Institutes of Health
Pinn, V. W. (1992) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30800-6 · Cited by 19
Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
Maksymiuk, A. W., Haines, C., Tan, L. K., et al. (1996) · PubMed · Cited by 6
Age-related prognostic factor analysis in non-Hodgkin's lymphoma (NHL)
Maksymiuk, A. W., Tan, L., & Skinnider, L. F. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)91594-b · Cited by 2
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Cited by
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Edwards, B. K., Howe, H. L., Ries, L. A. G., Thun, M. J., Rosenberg, H. M., Yancik, R., Wingo, P. A., Jemal, A., & Feigal, E. G. (2002) · Cancer · doi:10.1002/cncr.10593 · Cited by 880
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
The impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Metadata
- Authors
- Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-04-01
- Volume
- 21
- Issue
- 7
- Pages
- 1383-1389
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2126856198
- Cited by
- 1,031
- References
- 26
- FWCI
- 33.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.